158 related articles for article (PubMed ID: 25406200)
21. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
Westerberg PA; Linde T; Ljunggren O
Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
[No Abstract] [Full Text] [Related]
22. [A Case of Prostate Cancer with Multiple Bone Metastasis with High FGF23 Value Indicated by Intractable Hypocalcemia and Hypophosphatemia].
Nishida S; Shigesawa I; Nagai S; Itoh N; Masumori N
Hinyokika Kiyo; 2021 Jan; 67(1):47-51. PubMed ID: 33535298
[TBL] [Abstract][Full Text] [Related]
23. Tumour-induced osteomalacia: a rare cause of chronic pain and weakness.
Nasr JT; Tohme J; Collins MT; Drake MT; Hartley IR; Sfeir J; Dockery K; Taskin M
Pract Neurol; 2022 Dec; 22(6):528-531. PubMed ID: 35896375
[TBL] [Abstract][Full Text] [Related]
24. Osteomalacia by a mesenchymal-FGF23-producing tumour: Successful treatment with radiofrequency ablation. A case report.
Igney-Oertel A; Artunc F; Henes J; Hoffmann R; Clasen S
Joint Bone Spine; 2016 Oct; 83(5):603-4. PubMed ID: 27006265
[No Abstract] [Full Text] [Related]
25. Tumor-induced osteomalacia.
Jan de Beur SM
JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
[TBL] [Abstract][Full Text] [Related]
26. [Insulin-like growth factor-II secreting prostate tumour causing severe hypoglycaemi].
Vadász J; Barta G; Krasznai G; Ludger F; Zalatnai A
Orv Hetil; 2014 Aug; 155(33):1319-24. PubMed ID: 25109918
[TBL] [Abstract][Full Text] [Related]
27. [Hypophosphatemic oncogenic osteomalacia].
Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
[TBL] [Abstract][Full Text] [Related]
29. Acquired hypophosphatemic osteomalacia associated with multiple myeloma.
Narvaez J; Domingo-Domenech E; Narvaez JA; Nolla JM; Valverde J
Joint Bone Spine; 2005 Oct; 72(5):424-6. PubMed ID: 16112595
[TBL] [Abstract][Full Text] [Related]
30. Hypophosphatemic osteomalacia: association with prostatic carcinoma.
Lyles KW; Berry WR; Haussler M; Harrelson JM; Drezner MK
Ann Intern Med; 1980 Aug; 93(2):275-8. PubMed ID: 7406380
[TBL] [Abstract][Full Text] [Related]
31. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
[TBL] [Abstract][Full Text] [Related]
32. Tumor induced osteomalacia.
Filipová L; Lazúrová I
Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
[TBL] [Abstract][Full Text] [Related]
33. Tumour-induced osteomalacia (TIO).
Molendowska A; Jakubowska J; Jędrzejuk D; Szymczak J
Endokrynol Pol; 2022; 73(5):903-904. PubMed ID: 36621920
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.
Woznowski M; Quack I; Stegbauer J; Büchner N; Rump LC; Schieren G
Clin Nephrol; 2008 Nov; 70(5):431-8. PubMed ID: 19000546
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast Growth Factor 23-Induced Hypophosphatemia in Acute Leukemia.
Reinert RB; Bixby D; Koenig RJ
J Endocr Soc; 2018 May; 2(5):437-443. PubMed ID: 29696242
[TBL] [Abstract][Full Text] [Related]
36. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Bai X; Miao D; Li J; Goltzman D; Karaplis AC
Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
[TBL] [Abstract][Full Text] [Related]
37. [Tumoral hypophosphoremic osteomalacia].
Koeger AC; Prier A; Vinceneux P; Camus JP
Presse Med; 1985 Oct; 14(33):1747-51. PubMed ID: 2933649
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer-induced oncogenic hypophosphatemic osteomalacia.
Nakahama H; Nakanishi T; Uno H; Takaoka T; Taji N; Uyama O; Kitada O; Sugita M; Miyauchi A; Sugishita T
Urol Int; 1995; 55(1):38-40. PubMed ID: 7571183
[TBL] [Abstract][Full Text] [Related]
39. Tumor-induced Osteomalacia Caused by a Parotid Tumor.
Takashi Y; Kinoshita Y; Ito N; Taguchi M; Takahashi M; Egami N; Tajima S; Nangaku M; Fukumoto S
Intern Med; 2017; 56(5):535-539. PubMed ID: 28250301
[TBL] [Abstract][Full Text] [Related]
40. Left maxillary sinus tumour-induced hypophosphataemic osteomalacia and combined with thyroid papillary carcinoma: a case report and literature review.
Li B; Dong Y; Liu D; Yao Q; Guo S; Xin H; Wang H; Liu L; Zhang Y
Intern Med J; 2020 Jun; 50(6):755-761. PubMed ID: 32537923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
